Key facts
- This page summarizes Michael Thomas Heffernan's Form 4 filing for COLLEGIUM PHARMACEUTICAL, INC (COLL).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Feb 2025, 16:10.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Reflects the grant of fully-vested restricted stock units ("RSUs") granted as compensation for the Reporting Person's service as interim Chief Executive Officer in 2024. Each RSU represents a contingent right to receive one share of the Issuer's common stock.